I can't see the point in being "glass half empty" when I'm a holder of the stock. If and when I go "glass half empty", I'll sell.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025